Do Cost-Sharing and Entry Deregulation Curb Pharmaceutical Innovation?

Journal of Health Economics - Netherlands
doi 10.1016/j.jhealeco.2013.06.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost of Innovation in the Pharmaceutical Industry

Journal of Health Economics
Health PolicyPublic HealthOccupational HealthEnvironmental
1991English

Pharmaceutical Innovation and Parallel Trade

International Journal of Industrial Organization
Industrial RelationsIndustrialFinanceEconomicsManufacturing EngineeringStrategyManagementEconometricsAerospace Engineering
2014English

Introducing Innovation in Social Networks: A Cost-Benefit Analysis of Entry Point Selection

2015English

Consistent Cost Sharing

Mathematical Methods of Operations Research
Management ScienceSoftwareOperations ResearchMathematics
2011English

Cost Sharing Challenge

Veterinary Record
MedicineVeterinary
2006English

Profit Sharing as Entry Deterrence Mechanism

Portuguese Economic Journal
EconomicsEconometricsFinance
2016English

Financial Innovation, Deregulation and the "Credit View" of Monetary Policy

1996English

Innovation in the Pharmaceutical Industry

BMJ
1978English

Innovation in the Pharmaceutical Industry

Journal of the Royal Society of Medicine
Medicine
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy